Commercial Credit Report for Applied Biosciences Corp

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Applied Biosciences Corp is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Applied Biosciences Corp
320 PARK AVE
Phone: (212) 401-0097p:212 401-0097	NEW YORK, NY 10022 United States	Ticker: APPBAPPB

This company ceased filing statements with the SEC on 5/1/2020.
On 12/24/2018, the Company filed a Registration Withdrawal Request of its Form S-1 (File No. 333-228652) with the SEC, initially filed with the Commission on December 3, 2018. The Company is requesting withdrawal of the Registration Statement on the grounds that such withdrawal is consistent with the public interest and the protection of investors.

Business Summary

Applied BioSciences Corp. is a vertically integrated company that is focused on the development of science-driven cannabinoid therapeutics/biopharmaceuticals. The Company delivers cannabidiol (CBD) products as well as testing and analytics capabilities to its customers. It sells consumer products, including health and wellness creams, tinctures, edibles, confections, clothing, apparel, and other various branded products. Its various brands include Remedi, Remedi Plus, HerbalPet, Champ Organics and Equine Care. Its products are focused on the medical, bioceutical and pet health industries. The Company's subsidiaries include Applied Products LLC, Trace Analytics, Inc., and API Holdings, LLC, among others.

(Source: PROSPECTUS)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
-	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2019	3/31/2019	Yes	Yes	-	-	Yes

Industries

SIC Code	Description
8731	Commercial physical and biological research

Officers and Directors

Title	Name	Age	Title Date	Start Date
Chairman of the Board	ScottStevens		5/17/2019	4/15/2019
President, Director	ChrisBridges	40	3/9/2017	2/10/2017
Treasurer, Secretary	John J.Southard	42	9/21/2018	9/21/2018
Director	MichaelBeaubaire	51	10/3/2019	10/3/2019

Subsidiaries

Business Name	Address	City	State/Province	Country
Trace Analytics, Inc.	15768 Hamilton Pool Road	Austin	TX	United States

Business Names

Business Name
APPB
Applied Products LLC
FRRX
7 additional Business Names available in full report.

General Information

Outstanding Shares:	22,002,587	(As of 12/31/2021)
Stock Exchange:	OTC